Related Experiment Video
Updated: Aug 15, 2025

Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples
Published on: June 30, 2023
The Dutch see Red: (in)formal science advisory bodies during the COVID-19 pandemic
Janne Aarts1, Eva Gerth1, David Ludwig1
1Knowledge, Technology and Innovation Group, Wageningen University & Research, Hollandseweg 1, 6706 KN Wageningen, the Netherlands.
Abstract:
We analyse the roles, dynamics and logic of science advice in structuring the Dutch response to the COVID-19 pandemic, from January 2020 to December 2020. We address how the Dutch government responded by paying attention to styles of governance and expert advice. We argue that the Dutch response was shaped by the interplay of corporatist, deliberative and neoliberal forms of governance, in particular, how early corporatist tendencies seemed to create consensus during the first phase of the pandemic but quickly led to criticism and tension, most visibly at the onset of the second wave, as corporatist and neoliberal responses conflicted with deliberative and pluralist political engagement. Situating different science advisory bodies in this dynamic, we highlight how science-policy interactions and conflicts that evolved with the dynamics of the pandemic can be understood within this triad and as reflective broadly of the endurance of the Dutch model of polder governance.
More Related Videos
Related Concept Videos
Drug Control Governance: Regulatory Bodies and Their Impact
Principles of Disease Surveillance
Steps in Outbreak Investigation
Psychology as a Science
The scientific method in psychology involves six critical steps: making observations, formulating hypotheses, conducting tests, analyzing...
International Nursing Organizations II
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

